Boehringer Ingelheim and N-SIDE partner on innovative production planning optimization project

Boehringer Ingelheim Pharma has signed an agreement with N-SIDE to start a pilot project using N-SIDE’s risk-based production planning solution, CT-PRO. Boehringer Ingelheim joins other top pharmaceutical companies, such as Sanofi, who have recently partnered with N-SIDE for projects focused on production optimization.   The project will evaluate optimization opportunities for the supply chain of two early phase clinical compounds […]

read more

Join our presentation on drug manufacturing optimization in the pharmaceutical industry at the Orbel Conference

N-SIDE is proud to sponsor, as every year, the annual conference of the Belgian Operational Research Society (ORBEL) that will take place in the city of Liège at HEC Liège-Management School of ULiège, and will be organised by the HEC Liège Centre for Quantitative Methods and Operations Management (QuantOM). This year, our Head of Solutions Implementation, Charlotte Tannier, […]

read more
We are committed to respecting your privacy and protecting your personal data, including any information which allows us to identify you as an individual person. N-SIDE uses the personal data in a fair and lawful manner. N-SIDE collects and processes personal data in accordance with the privacy statement available on the link https://www.n-side.com/n-side-privacy-policy/.
v